Analysts Predict Significant Upside for SPTM and Key Holdings
At ETF Channel, we assessed the underlying holdings of various ETFs. We compared each holding’s trading price to the average analyst 12-month forward target price, and calculated the weighted average implied target price for the ETF. For the SPDR Portfolio S&P 1500 Composite Stock Market ETF (Symbol: SPTM), we found the implied analyst target price is $80.55 per unit.
Currently, SPTM is trading at approximately $62.48 per unit, indicating analysts project a 28.92% upside based on their targets for the ETF’s underlying holdings. Among these holdings, three stand out for their significant upside potential: Cytek BioSciences Inc (Symbol: CTKB), Viavi Solutions Inc (Symbol: VIAV), and Digi International Inc (Symbol: DGII). CTKB, with a recent trading price of $3.70 per share, has a target price that is 90.54% higher at $7.05 per share. VIAV shows 32.71% upside, moving from a current price of $9.67 towards an average target of $12.83 per share. Similarly, analysts expect DGII to reach a target price of $34.50 per share, reflecting a 32.29% increase from its recent price of $26.08. Below, we present a twelve-month price history chart comparing the stock performance of CTKB, VIAV, and DGII:
Here is a summary table of the current analyst target prices for these stocks:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| SPDR Portfolio S&P 1500 Composite Stock Market ETF | SPTM | $62.48 | $80.55 | 28.92% |
| Cytek BioSciences Inc | CTKB | $3.70 | $7.05 | 90.54% |
| Viavi Solutions Inc | VIAV | $9.67 | $12.83 | 32.71% |
| Digi International Inc | DGII | $26.08 | $34.50 | 32.29% |
Considering these insights, one might wonder: Are analysts justified in their targets, or are they overly optimistic about future trading prices? Did the analysts accurately account for recent developments in companies and industries, or are their expectations outdated? A high price target relative to a stock’s current trading price can imply optimism about growth ahead but may also signal potential downgrades if the targets do not align with current realities. Investors should conduct further research to draw informed conclusions.
10 ETFs With Most Upside To Analyst Targets »
also see:
• ZYXI YTD Return
• EMMA shares outstanding history
• MIR Options Chain
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
